| Gene therapy clinical trials worldwide to 2017: An update |
119 |
| Clinical advances of siRNA therapeutics |
24 |
| Long non-coding RNAs in cancer: Another layer of complexity |
20 |
| Delivery of CRISPR/Cas9 for therapeutic genome editing |
19 |
| TMPO-AS1 promotes cervical cancer progression by upregulating RAB14 via sponging miR-577 |
18 |
| Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis |
15 |
| Intra-articular injection of autologous adipose-derived mesenchymal stem cells in the treatment of knee osteoarthritis |
15 |
| Molecular functions and biological roles of long non-coding RNAs in human physiology and disease |
13 |
| MicroRNA expression data analysis to identify key miRNAs associated with Alzheimer's disease |
13 |
| Tumor microenvironment as the regulator and target for gene therapy |
11 |
| Cationic micelle: A promising nanocarrier for gene delivery with high transfection efficiency |
10 |
| Non-viral nucleic acid delivery to the central nervous system and brain tumors |
9 |
| Long non-coding RNA HCG11 suppresses the growth of glioma by cooperating with the miR-4425/MTA3 axis |
8 |
| Long non-coding RNA MIR22HG inhibits cell proliferation and migration in cholangiocarcinoma by negatively regulating the Wnt/-catenin signaling pathway |
7 |
| Clinical translation of gene medicine |
7 |
| Creating cell and animal models of human disease by genome editing using CRISPR/Cas9 |
6 |
| Non-viral gene delivery for cancer immunotherapy |
6 |
| Organic/inorganic nanohybrids as multifunctional gene delivery systems |
5 |
| Transcutaneous delivery of DNA/mRNA for cancer therapeutic vaccination |
5 |
| Virus-inspired and mimetic designs in non-viral gene delivery |
5 |
| Comparative analysis and optimization of protocols for producing recombinant lentivirus carrying the anti-Her2 chimeric antigen receptor gene |
5 |
| Epidermal growth factor receptor targeted methotrexate and small interfering RNA co-delivery |
5 |
| The evaluation of VEGF and HIF-1 alpha gene polymorphisms and multiple sclerosis susceptibility |
5 |
| Long non-coding RNAs (CASC2 and TUG1) in hepatocellular carcinoma: Clinical significance |
5 |
| MiR-6838-5p suppresses cell metastasis and the EMT process in triple-negative breast cancer by targeting WNT3A to inhibit the Wnt pathway |
5 |
| A novel mutation in SLC39A14 causing hypermanganesemia associated with infantile onset dystonia |
5 |
| MicroRNA-guided gene expression in prostate cancer: Literature and database overview |
5 |
| Identification of microRNA expression in sentinel lymph nodes from patients with breast cancer via RNA sequencing for diagnostic accuracy |
4 |
| Impact of cellular restriction gene (TRIM BST-2) polymorphisms on the acquisition of HIV-1 and disease progression |
4 |
| Arg399Gln substitution in XRCC1 as a prognostic and predictive biomarker for prostate cancer: Evidence from 8662 subjects and a structural analysis |
4 |
| LINC00673 rs11655237 C>T and susceptibility to Wilms tumor: A five-center case-control study |
4 |
| Identification of 17 mRNAs and a miRNA as an integrated prognostic signature for lung squamous cell carcinoma |
4 |
| Association between the LIPG polymorphisms and serum lipid levels in the Maonan and Han populations |
3 |
| ELK1-activated GPC3-AS1/GPC3 axis promotes the proliferation and migration of cervical cancer cells |
3 |
| A prospective study on associations between superoxide dismutase gene polymorphisms and antituberculosis drug-induced liver injury in a Chinese Han population |
3 |
| LncRNA CDKN2BAS rs2157719 genetic variant contributes to medulloblastoma predisposition |
3 |
| Diagnostic and prognostic significance of serum miRNA-146-a expression in Egyptian children with sepsis in a pediatric intensive care unit |
3 |
| Gene therapy for Glut1-deficient mouse using an adeno-associated virus vector with the human intrinsic GLUT1 promoter |
3 |
| Promoter polymorphisms in TGFB1 and IL10 genes influence tumor dendritic cells infiltration, development and prognosis of colorectal cancer |
3 |
| Development of a liver-specific Tet-off AAV8 vector for improved safety of insulin gene therapy for diabetes |
3 |
| Recent advances in gene-enhanced bone tissue engineering |
3 |
| A clinical guidance to DFNA22 drawn from a Korean cohort study with an autosomal dominant deaf population: A retrospective cohort study |
2 |
| MiR-21 ameliorates age-associated skin wound healing defects in mice |
2 |
| HIF-1 alpha promotes bone marrow stromal cell migration to the injury site and enhances functional recovery after spinal cord injury in rats |
2 |
| Association of IGFN1 variant with polypoidal choroidal vasculopathy |
2 |
| Polymer-coated viral vectors: hybrid nanosystems for gene therapy |
2 |
| Designer nuclease-mediated gene correction via homology-directed repair in an in vitro model of canine hemophilia B |
2 |
| Low penetrance genetic polymorphisms as potential biomarkers for colorectal cancer predisposition |
2 |
| HPV16(+)-miRNAs in cervical cancer and the anti-tumor role played by miR-5701 |
2 |
| A novel mutation (c.1010G>T; p.R337L) in TP63 as a cause of split-hand/foot malformation with hypodontia |
2 |
